Source: International Congress 2019 – Interventional pulmonology: current pleural practice
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
V. Pinelli (La Spezia, Italy), A. Bragantini (Genova, Italy), F. Novelli (La Spezia, Italy), M. Sivori (La Spezia, Italy), P. Canessa (La Spezia, Italy), V. Balestracci (La Spezia, Italy), G. Marchetti (Brescia, Italy). Thoracoscopic talc poudrage (TTP) in malignant (M) pleural effusion (PE): when to perform it?. 3130

Member's Comments

No comment yet.

Related content which might interest you: Treatment successes with talc pleurodesis at patients (pts.) with recurrent malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002 Thoracoscopic talc pleurodesis‘(TTP) safety and clinical efficacy in malignant pleural effusions (MPE) Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Prognostic factors associated to survival in patients with malignant pleural effusion (MPE) undergoing talc poudrage pleurodesis (TPP) Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE) Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002 The role of thoracoscopy in the diagnosis of malignant pleural effusions (PE) Source: Eur Respir J 2002; 20: Suppl. 38, 438s Year: 2002 Pleural effusion Source: Respipedia Article Year: 2017 CD8+ lymphocyte subpopulations in pleural fluid are associated with longer survival in patients with malignant pleural effusion (MPE) submitted to thoracoscopic talc pleurodesis Source: Eur Respir J 2002; 20: Suppl. 38, 70s Year: 2002 Malignant pleural effusions Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177 Year: 2002 Thoracoscopic talc poudrage induces T-lymphopenia Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Therapeutic local procedures: pleurodesis Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=311 Year: 2002 Importance of parietal pleural biopsy (PPB) in the diagnosis of etiology of pleural effusion (PE) Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Surgical problems with the malignant pleural space Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Difficult pleural effusion management (e.g., chylothorax, trapped lung and rheumatoid effusions) Source: International Congress 2017 – PG5 Pleural disease management Year: 2017 Thoracoscopic talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 72s Year: 2005 Thoracoscopic talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 172s Year: 2005 Talc pleurodesis in malignant pleural effusions: A 5-year experience Source: Annual Congress 2012 - Medical access to the pleura Year: 2012 Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE) Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001 Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 The impact of video-assisted thoracoscopy (VAT) on the management of malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 538s Year: 2002 Thoracoscopic tetracycline poudrage for pleurodesis in malignant pleural effusion Source: International Congress 2016 – Pleural diseases Year: 2016